Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- New Brunswick and Salt Lake City, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 450 people, planned
- Started
- 4 Sept 2023
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- MORE
- SMP
- TAU
- Record updated
- 30 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- English-speaking
- age ≥18
- currently on methadone
- persistent or recurring pain that has lasted for a duration of 3 months of longer
Who cannot take part
- previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33 studies)
- severe cognitive impairment (score >23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
- suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
- inability to attend or fully participate in intervention sessions or assessments
This trial is currently available in United States.
- Rutgers, Robert Wood Johnson Medical SchoolNew Brunswick, United StatesContact: Nina CoopermanTaking people
- University of UtahSalt Lake City, United StatesContact: Ericc Garland, PhDTaking people
About the trial
What the trial wants to find out
This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigators will also assess barriers and facilitators to integrating MORE into methadone treatment, and evaluate the impact of a sustainable train-the-trainer model on provider burden, intervention fidelity, intervention engagement, and outcomes. Participants will be assigned to a higher intensity MORE implementation strategy, a minimal intensity implementation strategy consisting of a simple, scripted mindfulness practice (SMP) extracted from the MORE treatment manual with minimal training and feedback and no supervision, or methadone treatment as usual (TAU). We aim to:
Read full original descriptionShow less
* Examine barriers and facilitators to the implementation of MORE and SMP in MT and evaluate strategies for optimizing training, fidelity, and engagement. * Evaluate the effectiveness and treatment fidelity of a higher intensity MORE implementation strategy versus a lower intensity, scripted mindfulness practice (SMP) implementation strategy as an adjunct to methadone TAU or methadone TAU, only. Outcomes include opioid and other drug use, craving, MT discontinuation, depression, anxiety, and physical pain (secondary outcomes) than patients randomized to TAU.
The 3 groups in the trial
- MORETreatment being tested
Eight group sessions of Mindfulness-Oriented Recovery Enhancement plus methadone treatment as usual (TAU)
- Scripted Mindfulness Practice (SMP)Existing treatment, for comparison
Eight group sessions of scripted mindfulness practice plus TAU.
Treatment: SMP
- Treatment-as-UsualExisting treatment, for comparison
Methadone treatment as usual.
Treatment: TAU
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use Disorder and Chronic Pain
- Publications
- Record updated
- 30 July 2025